There’s no escaping talk of weight loss medication in 2026. ‘Skinny jabs’ as they’re commonly known are filling newspaper column inches on a weekly basis and, as of April, it was reported that at least 1.6 million people in the UK had tried GLP-1 injections in the last year. That number is only expected to rise - especially as, from this week, a capsule tablet GLP-1 has hit the market.
And yet the likes of Ozempic, Mounjaro and Wegovy are still considered “controversial” - but “they don’t need to be,” says former Apprentice and Loose Women star, Saira Khan.
